Fermé C. et al. (2007. November). „Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.” (angol nyelven). N Engl J Med.357 (19), 1916-27. o. DOI:10.1056/NEJMoa064601. PMID17989384.
Shenoy P, Maggioncalda A, Malik N, Flowers CR. (2011. February). „Incidence patterns and outcomes for hodgkin lymphoma patients in the United States.” (angol nyelven). Adv Hematol.2011, 725219. o. DOI:10.1155/2011/725219. PMID21197477.
Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. (2006. december). „Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.” (angol nyelven). Blood.108 (12), 3786-91. o. DOI:10.1182/blood-2006-05-024109. PMID16917006.
Schwering I, Bräuninger A, Klein U, Jungnickel B, Tinguely M, Diehl V, Hansmann ML, Dalla-Favera R, Rajewsky K, Küppers R. (2003. February). „Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.” (angol nyelven). Blood.101 (4), 1505-12. o. DOI:10.1182/blood-2002-03-0839. PMID12393731.
Stein H, Bob R. (2009. July). „Is Hodgkin lymphoma just another B-cell lymphoma?” (angol nyelven). Curr Hematol Malig Rep.4 (3), 125-8. o. DOI:10.1007/s11899-009-0018-1. PMID20425425.
Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. (2011. May). „The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.” (angol nyelven). Blood.117 (19), 5019-32. o. DOI:10.1182/blood-2011-01-293050. PMID21300984.
Hawkes EA, Wotherspoon A, Cunningham D. (2012. March). „The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.” (angol nyelven). Leuk Lymphoma.53 (3), 354-61. o. DOI:10.3109/10428194.2011.608455. PMID21812538.
Mani H, Jaffe ES. (2009. June). „Hodgkin lymphoma: an update on its biology with new insights into classification.” (angol nyelven). Clin Lymphoma Myeloma.9 (3), 206-16. o. DOI:10.3816/CLM.2009.n.042. PMID19525189.
Rizos E, Milionis HJ, Pavlidis N, Elisaf MS. (2002. December). „Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin's disease.” (angol nyelven). Lancet Oncol.3 (12), 727. o. DOI:10.1016/S1470-2045(02)00928-2. PMID12473513.
Oh BC, Lim YM, Kwon YM, Khang SK, Kim KK. (2004. February). „A case of Hodgkin's lymphoma associated with sensory neuropathy.” (angol nyelven). J Korean Med Sci.19 (1), 130-3. o. DOI:10.3346/jkms.2004.19.1.130. PMID14966355.
Audard V, Zhang SY, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, Baia M, Lang P, Pawlak A, Sahali D. (2010. May). „Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.” (angol nyelven). Blood.115 (18), 3756-62. o. DOI:10.1182/blood-2009-11-251132. PMID20200355.
Rizvi I, Zaman S, Zaidi N, Ashraf SM, Kumar A, Gupta A, Ahmad M. (2012. February). „Superior vena cava syndrome caused by Hodgkin's lymphoma in an adolescent girl.” (angol nyelven). BMJ Case Rep.21. DOI:10.1136/bcr.01.2012.5487. PMID22665460.
Kuruvilla J. (2009). „Standard therapy of advanced Hodgkin lymphoma.” (angol nyelven). Hematology Am Soc Hematol Educ Program., 497-506. o. DOI:10.1182/asheducation-2009.1.497. PMID20008235.
Bauer K, Skoetz N, Monsef I, Engert A, Brillant C. (2011. August). „Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.” (angol nyelven). Cochrane Database Syst Rev.10 (8), CD007941. o. DOI:10.1002/14651858.CD007941.pub2. PMID21833963.
Viviani S, et al. (2011. July). „ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.” (angol nyelven). N Engl J Med.365 (3), 203-12. o. DOI:10.1056/NEJMoa1100340. PMID21774708.
Engert A, Haverkamp H, Kobe C, et al. (2012. May). „Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.” (angol nyelven). Lancet.379 (9828), 1791-9. o. DOI:10.1016/S0140-6736(11)61940-5. PMID22480758.
Rancea M, Engert A, von Tresckow B, Halbsguth T, Behringer K, Skoetz N. (2013. March). „Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.” (angol nyelven). Dtsch Arztebl Int.110 (11), 177-83. o. DOI:10.3238/arztebl.2013.0177. PMID23555321.
Sweetenham JW. (2010. February). „Novel therapies for Hodgkin Lymphoma.” (angol nyelven). Ther Adv Hematol.1 (1), 23-9. o. DOI:10.1177/2040620710387980. PMID23556069.
Schulz H, Rehwald U, Morschhauser F, et al. (2008. January). „Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).” (angol nyelven). Blood.111 (1), 109-11. o. DOI:10.1182/blood-2007-03-078725. PMID17938252.
Saini KS, Azim HA Jr, Cocorocchio E, et al. (2011. August). „Rituximab in Hodgkin lymphoma: is the target always a hit?” (angol nyelven). Cancer Treat Rev.37 (5), 385-90. o. DOI:10.1016/j.ctrv.2010.11.005. PMID21183282.
Newland AM, Li JX, Wasco LE, et al. (2013. January). „Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate.” (angol nyelven). Pharmacotherapy.33 (1), 93-104. o. DOI:10.1002/phar.1170. PMID23307550.
Adams MJ, Constine LS, Lipshultz SE. (2007. July). „Late effects of therapy for Hodgkin's lymphoma.” (angol nyelven). Curr Hematol Malig Rep.2 (3), 143-50. o. DOI:10.1007/s11899-007-0020-4. PMID20425363.
Ng AK, Mauch PM. (2009. March-April). „Late effects of Hodgkin's disease and its treatment.” (angol nyelven). Cancer J.15 (2), 164-8. o. DOI:10.1097/PPO.0b013e31819e30d7. PMID19390314.
Hasenclever D, Diehl V. (1998. November). „A prognostic score for advanced Hodgkin's disease.” (angol nyelven). N Engl J Med.339 (21), 1506-14. o. DOI:10.1056/NEJM199811193392104. PMID9819449.
Hodgkin. (1832). „On some Morbid Appearances of the Absorbent Glands and Spleen.” (angol nyelven). Med Chir Trans.17, 68-114. o. PMID2089559. PMC2116706.
Fermé C. et al. (2007. November). „Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.” (angol nyelven). N Engl J Med.357 (19), 1916-27. o. DOI:10.1056/NEJMoa064601. PMID17989384.
Shenoy P, Maggioncalda A, Malik N, Flowers CR. (2011. February). „Incidence patterns and outcomes for hodgkin lymphoma patients in the United States.” (angol nyelven). Adv Hematol.2011, 725219. o. DOI:10.1155/2011/725219. PMID21197477.
Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. (2006. december). „Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.” (angol nyelven). Blood.108 (12), 3786-91. o. DOI:10.1182/blood-2006-05-024109. PMID16917006.
Schwering I, Bräuninger A, Klein U, Jungnickel B, Tinguely M, Diehl V, Hansmann ML, Dalla-Favera R, Rajewsky K, Küppers R. (2003. February). „Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.” (angol nyelven). Blood.101 (4), 1505-12. o. DOI:10.1182/blood-2002-03-0839. PMID12393731.
Stein H, Bob R. (2009. July). „Is Hodgkin lymphoma just another B-cell lymphoma?” (angol nyelven). Curr Hematol Malig Rep.4 (3), 125-8. o. DOI:10.1007/s11899-009-0018-1. PMID20425425.
Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. (2011. May). „The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.” (angol nyelven). Blood.117 (19), 5019-32. o. DOI:10.1182/blood-2011-01-293050. PMID21300984.
Hawkes EA, Wotherspoon A, Cunningham D. (2012. March). „The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.” (angol nyelven). Leuk Lymphoma.53 (3), 354-61. o. DOI:10.3109/10428194.2011.608455. PMID21812538.
Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. (1993. March). „Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis.” (angol nyelven). Cancer.71 (6), 2062-71. o. PMID8443755.
Mani H, Jaffe ES. (2009. June). „Hodgkin lymphoma: an update on its biology with new insights into classification.” (angol nyelven). Clin Lymphoma Myeloma.9 (3), 206-16. o. DOI:10.3816/CLM.2009.n.042. PMID19525189.
BICHEL J, BASTRUP-MADSEN P. (1953. April). „Alcohol pain in Hodgkin's disease.” (angol nyelven). Lancet.1 (6764), 764-6. o. PMID13036159.
Bobrove AM. (1983. June). „Alcohol-related pain and Hodgkin's disease.” (angol nyelven). West J Med.138 (6), 874-5. o. PMID6613116.
Rizos E, Milionis HJ, Pavlidis N, Elisaf MS. (2002. December). „Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin's disease.” (angol nyelven). Lancet Oncol.3 (12), 727. o. DOI:10.1016/S1470-2045(02)00928-2. PMID12473513.
Oh BC, Lim YM, Kwon YM, Khang SK, Kim KK. (2004. February). „A case of Hodgkin's lymphoma associated with sensory neuropathy.” (angol nyelven). J Korean Med Sci.19 (1), 130-3. o. DOI:10.3346/jkms.2004.19.1.130. PMID14966355.
Kung S, Mueller PS, Geda YE, Krahn LE. (2002. November-December). „Delirium resulting from paraneoplastic limbic encephalitis caused by Hodgkin's disease.” (angol nyelven). Psychosomatics.43 (6), 498-501. o. PMID12444235.
Audard V, Zhang SY, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, Baia M, Lang P, Pawlak A, Sahali D. (2010. May). „Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.” (angol nyelven). Blood.115 (18), 3756-62. o. DOI:10.1182/blood-2009-11-251132. PMID20200355.
Rizvi I, Zaman S, Zaidi N, Ashraf SM, Kumar A, Gupta A, Ahmad M. (2012. February). „Superior vena cava syndrome caused by Hodgkin's lymphoma in an adolescent girl.” (angol nyelven). BMJ Case Rep.21. DOI:10.1136/bcr.01.2012.5487. PMID22665460.
Bauer K, Skoetz N, Monsef I, Engert A, Brillant C. (2011. August). „Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.” (angol nyelven). Cochrane Database Syst Rev.10 (8), CD007941. o. DOI:10.1002/14651858.CD007941.pub2. PMID21833963.
Diehl V, Fuchs M; GHSG. (2007. August). „Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?” (angol nyelven). Transfus Apher Sci.7 (1), 37-41. o. PMID17714996.
Viviani S, et al. (2011. July). „ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.” (angol nyelven). N Engl J Med.365 (3), 203-12. o. DOI:10.1056/NEJMoa1100340. PMID21774708.
Engert A, Haverkamp H, Kobe C, et al. (2012. May). „Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.” (angol nyelven). Lancet.379 (9828), 1791-9. o. DOI:10.1016/S0140-6736(11)61940-5. PMID22480758.
Rancea M, Engert A, von Tresckow B, Halbsguth T, Behringer K, Skoetz N. (2013. March). „Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.” (angol nyelven). Dtsch Arztebl Int.110 (11), 177-83. o. DOI:10.3238/arztebl.2013.0177. PMID23555321.
Sweetenham JW. (2010. February). „Novel therapies for Hodgkin Lymphoma.” (angol nyelven). Ther Adv Hematol.1 (1), 23-9. o. DOI:10.1177/2040620710387980. PMID23556069.
Schulz H, Rehwald U, Morschhauser F, et al. (2008. January). „Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).” (angol nyelven). Blood.111 (1), 109-11. o. DOI:10.1182/blood-2007-03-078725. PMID17938252.
Saini KS, Azim HA Jr, Cocorocchio E, et al. (2011. August). „Rituximab in Hodgkin lymphoma: is the target always a hit?” (angol nyelven). Cancer Treat Rev.37 (5), 385-90. o. DOI:10.1016/j.ctrv.2010.11.005. PMID21183282.
Newland AM, Li JX, Wasco LE, et al. (2013. January). „Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate.” (angol nyelven). Pharmacotherapy.33 (1), 93-104. o. DOI:10.1002/phar.1170. PMID23307550.
Adams MJ, Constine LS, Lipshultz SE. (2007. July). „Late effects of therapy for Hodgkin's lymphoma.” (angol nyelven). Curr Hematol Malig Rep.2 (3), 143-50. o. DOI:10.1007/s11899-007-0020-4. PMID20425363.
Ng AK, Mauch PM. (2009. March-April). „Late effects of Hodgkin's disease and its treatment.” (angol nyelven). Cancer J.15 (2), 164-8. o. DOI:10.1097/PPO.0b013e31819e30d7. PMID19390314.
Hasenclever D, Diehl V. (1998. November). „A prognostic score for advanced Hodgkin's disease.” (angol nyelven). N Engl J Med.339 (21), 1506-14. o. DOI:10.1056/NEJM199811193392104. PMID9819449.
Dawson PJ. (1999. December). „The original illustrations of Hodgkin's disease.” (angol nyelven). Ann Diagn Pathol.3 (6), 386-93. o. PMID10594291.
Geller SA. (1984. August). „Comments on the anniversary of the description of Hodgkin's disease.” (angol nyelven). J Natl Med Assoc.76 (8), 815-7. o. PMID6381744.
Zwitter M, Cohen JR, Barrett A, Robinton ED. (2002. June). „Dorothy Reed and Hodgkin's disease: a reflection after a century.” (angol nyelven). Int J Radiat Oncol Biol Phys.53 (2), 366-75. o. PMID12023141.
Smetana HF, Cohen BM. (1956. March). „Mortality in relation to histologic type in Hodgkin's disease.” (angol nyelven). Blood.11 (3), 211-24. o. PMID13293197.
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, et al. (1994. September). „A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.” (angol nyelven). Blood.84 (5), 1361-92. o. PMID8068936.
ncbi.nlm.nih.gov
Hodgkin. (1832). „On some Morbid Appearances of the Absorbent Glands and Spleen.” (angol nyelven). Med Chir Trans.17, 68-114. o. PMID2089559. PMC2116706.
